BioNTech SE Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7,675	9,762	11,664	13,875	1,693
Short-Term Investments	6,065	6,082	4,885	189.4	381.6
Cash & Short-Term Investments	13,741	15,844	16,549	14,065	2,074
Cash Growth	-13.28%	-4.26%	17.66%	578.04%	53.95%
Accounts Receivable	932.3	1,474	2,161	7,146	12,382
Other Receivables	52.6	50	179.1	0.4	0.4
Receivables	1,879	1,978	2,340	7,146	12,382
Inventory	110.7	283.3	357.7	439.6	502.5
Other Current Assets	416.2	698.2	280.9	271.9	113.4
Total Current Assets	16,147	18,804	19,527	21,922	15,072
Property, Plant & Equipment	1,291	1,183	971.6	821.1	520.4
Long-Term Investments	2,454	1,213	1,176	80.2	21.3
Goodwill	367.9	380.6	362.5	61.2	57.8
Other Intangible Assets	1,606	790.4	781.7	145.4	136.8
Long-Term Accounts Receivable	2	9.8	-	-	-
Long-Term Deferred Tax Assets	13.5	81.7	81.3	229.6	-
Other Long-Term Assets	107.3	67.2	105.8	19.6	22.2
Total Assets	21,989	22,530	23,006	23,279	15,831
Accounts Payable	534.9	426.7	354	204.1	160
Current Portion of Long-Term Debt	7.2	-	-	-	102
Current Portion of Leases	45	39.5	28.1	36	27.9
Current Income Taxes Payable	65.6	4.5	525.5	595.9	1,569
Current Unearned Revenue	754.9	294.9	353.3	77.1	186.1
Other Current Liabilities	734.7	1,758	809.6	2,038	1,437
Total Current Liabilities	2,142	2,523	2,071	2,951	3,482
Long-Term Debt	29.9	-	2.4	2.1	17.9
Long-Term Leases	185.3	214.7	188.6	174.1	153.7
Long-Term Unearned Revenue	88	183	398.5	48.4	9
Long-Term Deferred Tax Liabilities	84.3	42.4	39.7	6.2	66.7
Other Long-Term Liabilities	234.6	155.3	60.7	42.1	208.2
Total Liabilities	2,764	3,119	2,760	3,224	3,937
Common Stock	259	248.6	248.6	248.6	246.3
Retained Earnings	17,962	19,098	19,763	18,833	9,883
Treasury Stock	-7.7	-8.6	-10.8	-5.3	-3.8
Comprehensive Income & Other	1,011	73.1	244.8	979.3	1,768
Total Common Equity	19,224	19,411	20,246	20,056	11,894
Shareholders' Equity	19,224	19,411	20,246	20,056	11,894
Total Liabilities & Equity	21,989	22,530	23,006	23,279	15,831
Total Debt	267.4	254.2	219.1	212.2	301.5
Net Cash (Debt)	13,473	15,590	16,330	13,852	1,773
Net Cash Growth	-13.58%	-4.53%	17.89%	681.38%	60.10%
Net Cash Per Share	55.74	64.85	67.28	55.45	6.83
Filing Date Shares Outstanding	239.97	239.97	237.73	240.99	242.52
Total Common Shares Outstanding	251.33	239.97	237.73	243.22	242.52
Working Capital	14,004	16,280	17,457	18,971	11,591
Book Value Per Share	76.49	80.89	85.16	82.46	49.04
Tangible Book Value	17,250	18,240	19,102	19,849	11,699
Tangible Book Value Per Share	68.64	76.01	80.35	81.61	48.24
Land	586.4	369.4	235.4	217	104.1
Machinery	491.5	427.7	344.1	273	198.3
Construction In Progress	478.5	460.6	389.5	235.5	94.3

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.